123 related articles for article (PubMed ID: 9094186)
1. Polyclonal Ki-67 expression in transitional cell carcinoma of the bladder.
Jones HL; Delahunt B; Bethwaite PB; Thornton A
Pathology; 1997 Feb; 29(1):84-7. PubMed ID: 9094186
[TBL] [Abstract][Full Text] [Related]
2. Luminal epithelial antigen (LEA.135) expression correlates with tumor progression for transitional carcinoma of the bladder.
Jones HL; Delahunt B; Bethwaite PB; Thornton A
Anticancer Res; 1997; 17(1B):685-7. PubMed ID: 9066602
[TBL] [Abstract][Full Text] [Related]
3. [Monoclonal antibodies against transitional cell carcinoma assay tumor associated antigens in different grades bladder cancer patients].
Zhang H; Zhao Z; Sun H
Zhonghua Wai Ke Za Zhi; 1996 Sep; 34(9):560-2. PubMed ID: 9594163
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and its correlation with grading and staging on tissue sections of urinary bladder carcinomas.
Jautzke G; Altenaehr E
Cancer; 1982 Nov; 50(10):2052-6. PubMed ID: 6751517
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of proliferating cell nuclear antigen, Ki-67 and nucleolar organizer region in transitional cell carcinoma of the bladder.
Bozlu M; Orhan D; Baltaci S; Yaman O; Elhan AH; Tulunay O; Müftüoğlu YZ
Int Urol Nephrol; 2002; 33(1):59-66. PubMed ID: 12090340
[TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical study of p53 and Ki-67 antigen expression in bladder carcinoma].
Yuge F; Hirakata H; Igarashi H; Kodama M; Kawata N; Takimoto Y
Hinyokika Kiyo; 1999 Jul; 45(7):453-6. PubMed ID: 10466059
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical study of tissue polypeptide antigen (TPA) in human urinary bladder tumors].
Kaneko K; Suzuki T; Takasaki E
Nihon Hinyokika Gakkai Zasshi; 1989 Oct; 80(10):1430-5. PubMed ID: 2601216
[TBL] [Abstract][Full Text] [Related]
8. Correlation of mitotic indices, AgNor count, Ki-67 and Bcl-2 with grade and stage in papillary urothelial bladder cancer.
Goyal S; Singh UR; Sharma S; Kaur N
Urol J; 2014 Mar; 11(1):1238-47. PubMed ID: 24595931
[TBL] [Abstract][Full Text] [Related]
9. Prostate stem cell antigen is overexpressed in human transitional cell carcinoma.
Amara N; Palapattu GS; Schrage M; Gu Z; Thomas GV; Dorey F; Said J; Reiter RE
Cancer Res; 2001 Jun; 61(12):4660-5. PubMed ID: 11406532
[TBL] [Abstract][Full Text] [Related]
10. Expression of squamous cell carcinoma-associated antigen in grade 3 pT1 transitional cell carcinoma of the bladder and prediction of its progression and intravesical recurrence.
Yamazaki K; Kumamoto Y; Tsukamoto T
Cancer; 1993 Dec; 72(12):3676-84. PubMed ID: 7902777
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in bladder carcinoma: histologic parameters and expression of a cell cycle-related nuclear antigen (Ki-67).
Mulder AH; Van Hootegem JC; Sylvester R; ten Kate FJ; Kurth KH; Ooms EC; Van der Kwast TH
J Pathol; 1992 Jan; 166(1):37-43. PubMed ID: 1538273
[TBL] [Abstract][Full Text] [Related]
12. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.
King ED; Matteson J; Jacobs SC; Kyprianou N
J Urol; 1996 Jan; 155(1):316-20. PubMed ID: 7490878
[TBL] [Abstract][Full Text] [Related]
13. [The prognostic value of KI-67 proliferation index in transitional cell carcinoma of renal pelvis and ureter].
Korneev IA
Vopr Onkol; 2005; 51(2):211-5. PubMed ID: 16223003
[TBL] [Abstract][Full Text] [Related]
14. DNA flow cytometry and 67Ki proliferating index as prognostic factors of early recurrence and progression in G1-G2/Ta-T1 and G3/Ta-T1 transitional cell carcinoma of the bladder.
Tizzani A; Casetta G; Gontero P; Giammò A; Ghabin H; Demurtas S; Pacchioni D
Minerva Urol Nefrol; 1997 Sep; 49(3):141-3. PubMed ID: 9396221
[TBL] [Abstract][Full Text] [Related]
15. Cyclin E overexpression in transitional cell carcinoma of the bladder.
Makiyama K; Masuda M; Takano Y; Iki M; Asakura T; Suwa Y; Noguchi S; Hosaka M
Cancer Lett; 2000 Apr; 151(2):193-8. PubMed ID: 10738114
[TBL] [Abstract][Full Text] [Related]
16. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
Igawa M
Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
[TBL] [Abstract][Full Text] [Related]
17. Potential value of antisera to epithelial membrane antigen in detecting early invasion in transitional cell carcinoma.
Pocock RD; Ibrahim SK; Sloane JP; Ponder BA; Shearer RJ
Br J Urol; 1983 Dec; 55(6):670-5. PubMed ID: 6652437
[TBL] [Abstract][Full Text] [Related]
18. P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma.
Krüger S; Mahnken A; Kausch I; Feller AC
Eur Urol; 2005 Apr; 47(4):463-7. PubMed ID: 15774242
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical demonstration of tumor-associated antigens with the aid of monoclonal and polyclonal antisera in carcinoma of the bladder.
Steffens J; Friedmann W; Lobeck H
Urol Res; 1985; 13(2):55-9. PubMed ID: 2409654
[TBL] [Abstract][Full Text] [Related]
20. Improved objectivity of grading of T(A,1) transitional cell carcinomas of the urinary bladder by quantitative nuclear and proliferation related features.
Bol MG; Baak JP; de Bruin PC; Rep S; Marx W; Bos S; Kisman O
J Clin Pathol; 2001 Nov; 54(11):854-9. PubMed ID: 11684720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
